Rocket lab misses on EPS, guides in line amid launch momentum

Rocket Lab USA (NASDAQ:RKLB) shares fell 2% after-hours following its Q2 earnings, where record revenue of $144.5 million, surpassing consensus, was overshadowed by a wider-than-expected adjusted net loss of $0.13 per share and significantly increased R&D spending. Despite strong top-line growth and strategic investments, investors focused on the continued operating losses, signaling ongoing concerns about the company's clear path to profitability.

Analysis

Rocket Lab USA, Inc. (RKLB) presented a bifurcated second-quarter earnings report, triggering a 2% after-hours share price decline despite achieving record top-line results. The company's revenue surged to a record $144.5 million, surpassing consensus estimates of $134.3 million, driven by a record cadence of five Electron launches. However, this revenue strength was overshadowed by a wider-than-expected adjusted net loss of $0.13 per share, compared to the $0.09 loss analysts had forecast. The increased loss is directly attributable to a significant ramp-up in R&D spending, which jumped to $66.1 million from $39.9 million in the prior-year period, as the company invests heavily in its next-generation Neutron rocket and integrates the pending Geost acquisition. While management expressed confidence that these strategic investments will secure long-term profitability and issued in-line Q3 guidance for revenue between $145 million and $155 million, the market's immediate focus remains on the continued operating losses. The results underscore the central tension for investors: balancing impressive operational execution and revenue growth against the mounting costs and uncertain timeline for achieving profitability.

Key Decisions for Investors

• Investors with a higher risk tolerance may consider the after-hours dip a buying opportunity, focusing on the strong revenue growth, positive Q3 guidance, and strategic pipeline including the Neutron rocket and key defense contracts.
• More cautious investors should closely monitor the company's cash burn and R&D expenditures, as the market is signaling that sustained operating losses are a primary concern overriding top-line performance.
• It is critical to track the company's progress toward its projected GAAP gross margins of 35% to 37% in Q3, as achieving this target would be a key indicator of its ability to translate record revenue into a sustainable business model.